Glaucoma Screening to Enhance At-Risk Californians' Health

Part of paid clinical trials in Oakland, California.

Sponsor
University of California, San Francisco
Study ID
NCT06854198
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Glaucoma screening with optical coherence tomography (OCT), color fundus photography, and tonometry — OTHER
    Participants will be called and offered a screening appointment. At the appointment, visual acuity, OCT, color fundus photography, tonometry, and visual field testing will be performed. The images will be assessed for abnormalities. Participants meeting referral criteria will be referred for a comprehensive eye examination with an eye care provider.
  • Educational Brochure — OTHER
    A brochure about glaucoma screening will be mailed to participants. The brochure will include contact information of a staff member who can schedule an appointment for a comprehensive eye examination.

Study Details

The vast majority of glaucoma cases in the United States go undetected and untreated until the late stages of the disease. Open-angle glaucoma is a progressive condition that is asymptomatic in its early to moderate stages and may be amenable to screening through telemedicine-based approaches. This study is a randomized trial to evaluate whether glaucoma screening with established tests (e.g., optical coherence tomography, fundus photography, and tonometry) is more effective for detecting undiagnosed glaucoma cases compared to education alone or delayed intervention.

Key Dates

Start date
Feb 10, 2026
Status verified
Apr 2026
Primary completion
Mar 31, 2029
Completion
Sep 30, 2029

Study Design

Enrollment
2,000 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING

Arms

  • Experimental: Screening
  • Active Comparator: Education
  • No Intervention: Delayed Education
    The same as the Educational Brochure arm, but delivered at the conclusion of the study.

Primary Outcome Measure

Glaucoma Diagnosis or Glaucoma Suspect Requiring Treatment [ Time Frame: 3 months from randomization ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Baywell HealthOaklandCalifornia94607
Angela Shahbazian, OD, FAAO
[email protected]
(510) 835-9610
University of California, San FranciscoSan FranciscoCalifornia94158-

Find similar trials in Oakland, CA

By condition
Glaucoma
By specialty
Ophthalmology
By research site
Baywell Health· Oakland, CAUniversity of California, San Francisco· San Francisco, CA

Related Studies